Table 3.
Postoperative characteristics of patients among two groups
| Group N (n = 196) |
Group P (n = 205) |
P-value | |
|---|---|---|---|
| POD, n (%) | 38(19.39%) | 43(20.98%) | 0.692 |
| POD duration n, (%) | 0.928 | ||
| Non-POD n, (%) | 158(80.61%) | 162(79.02%) | |
| 0 to 6 h n, (%) | 22(11.22%) | 26(12.68%) | |
| 6 to 12 h n, (%) | 9(4.59%) | 11(5.37%) | |
| > 12 h n, (%) | 7(3.57%) | 6(2.93%) | |
| Postoperative MDAS score (point, ± s) | 8.17 ± 3.44 | 8.36 ± 3.37 | 0.571 |
| Postoperative 24 h NRS score (point, ± s) | 1.98 ± 1.29 | 2.06 ± 1.22 | 0.505 |
| Abnormal muscle weakness, n (%) | 0(0%) | 0(0%) | |
| PONV, n (%) | 24(12.24%) | 22(10.73%) | 0.635 |
| Gastrointestinal complications, n (%) | 35(17.86%) | 48(23.41%) | 0.170 |
| Wound bleeding and infection, n (%) | 13(6.63%) | 17(8.29%) | 0.528 |
| POPCs, n (%) | 42(21.43%) | 63(30.73%) | 0.034* |
| Cardiac complications, n (%) | 3(1.53%) | 2(0.98%) | 0.679 |
| Cerebrovascular complications, n (%) | 1(0.51%) | 2(0.98%) | 1.000 |
| Postoperative hospital stay (day, ± s) | 12.44 ± 2.78 | 12.54 ± 2.50 | 0.726 |
| Mortality in 6 months, n (%) | 3(1.53%) | 4(1.96%) | 1.000 |
Abbreviation: PONV Postoperative nausea and vomiting, POPCs Postoperative pulmonary complications
*P < 0.05 in comparison with group P